Literature DB >> 14668707

Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.

Michael R Rudnick1, Stanley Goldfarb.   

Abstract

Experimental studies suggest that the pathogenesis of contrast media nephrotopathy is due to a combination of renal ischemia and direct tubular epithelial cell toxicity. Clinical studies to date have demonstrated a reduction in clinical contrast nephropathy with the introduction of low-osmolar and, more recently, iso-osmolar contrast media. Numerous experimental studies have examined the role of osmolality per se in the pathogenesis of contrast nephropathy, with conflicting results. Whether iso-osmolar contrast media are the least nephrotoxic iodinated contrast media needs to be determined with large prospective randomized clinical trials.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668707

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  10 in total

Review 1.  High-resolution CT vascular imaging using blood pool contrast agents.

Authors:  Ananth V Annapragada; Eric Hoffman; Abhay Divekar; Efstathios Karathanasis; Ketan B Ghaghada
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

2.  Iloprost for prevention of contrast-mediated nephropathy in high-risk patients undergoing a coronary procedure. Results of a randomized pilot study.

Authors:  K Spargias; E Adreanides; G Giamouzis; S Karagiannis; A Gouziouta; A Manginas; V Voudris; G Pavlides; D V Cokkinos
Journal:  Eur J Clin Pharmacol       Date:  2006-07-11       Impact factor: 2.953

3.  A randomized controlled trial comparing hydration therapy to additional hemodialysis or N-acetylcysteine for the prevention of contrast medium-induced nephropathy: the Dialysis-versus-Diuresis (DVD) Trial.

Authors:  H Reinecke; M Fobker; J Wellmann; B Becke; J Fleiter; C Heitmeyer; G Breithardt; H-W Hense; R M Schaefer
Journal:  Clin Res Cardiol       Date:  2006-12-22       Impact factor: 5.460

Review 4.  Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis.

Authors:  Somjot S Brar; Swapnil Hiremath; George Dangas; Roxana Mehran; Simerjeet K Brar; Martin B Leon
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

5.  Contrast media-induced nephropathy: case report and review of the literature focusing on pathogenesis.

Authors:  G Efstratiadis; P Pateinakis; G Tambakoudis; A Pantzaki; D Economidou; D Memmos
Journal:  Hippokratia       Date:  2008-04       Impact factor: 0.471

6.  Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.

Authors:  Martin Zo'o; Marcus Hoermann; Csilla Balassy; Francis Brunelle; Robin Azoulay; Danièle Pariente; Michel Panuel; Patrick Le Dosseur
Journal:  Pediatr Radiol       Date:  2011-06-29

Review 7.  Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.

Authors:  Guido van den Berk; Sanne Tonino; Carola de Fijter; Watske Smit; Marcus J Schultz
Journal:  Crit Care       Date:  2005-01-07       Impact factor: 9.097

8.  Preventive effect of pentoxifylline on contrast-induced acute kidney injury in hypercholesterolemic rats.

Authors:  Shi-Kun Yang; Shao-Bin Duan; Peng Pan; Xiang-Qing Xu; Na Liu; Jun Xu
Journal:  Exp Ther Med       Date:  2014-12-15       Impact factor: 2.447

9.  Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis.

Authors:  Jing-Xiu Li; En-Ze Jin; Long-Hao Yu; Yang Li; Nan-Nan Liu; Yu-Mei Dong; Xin Li; Xue-Qi Li
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

Review 10.  Is contrast medium osmolality a causal factor for contrast-induced nephropathy?

Authors:  Andreas M Bucher; Carlo N De Cecco; U Joseph Schoepf; Felix G Meinel; Aleksander W Krazinski; James V Spearman; Andrew D McQuiston; Rui Wang; Judith Bucher; Thomas J Vogl; Richard W Katzberg
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.